Article info

Download PDFPDF

Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
Free

Authors

  • Nir Eyal Center for Population-Level Bioethics, Department of Philosophy (SAS) and Department of HBSP (SPH), Rutgers University, New Brunswick, New Jersey, USA PubMed articlesGoogle scholar articles
  • Tobias Gerhard Center for Pharmacoepidemiology and Treatment Science and Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, New Jersey, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Nir Eyal, Center for Population-Level Bioethics, Dept of Philosophy (SAS) and Dept of HBSP (SPH), Rutgers University, New Brunswick, New Jersey, USA; nir.eyal{at}rutgers.edu
View Full Text

Citation

Eyal N, Gerhard T
Do coronavirus vaccine challenge trials have a distinctive generalisability problem?

Publication history

  • Received November 26, 2020
  • Revised March 10, 2021
  • Accepted April 20, 2021
  • First published June 7, 2021.
Online issue publication 
August 22, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you